- Home
- PRME vs CIO Comparison
PRME vs CIO Comparison
Compare PRME & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- CIO
- Stock Information
- Founded
- PRME 2019
- CIO 2013
- Country
- PRME United States
- CIO Canada
- Employees
- PRME N/A
- CIO N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- CIO Real Estate Investment Trusts
- Sector
- PRME Health Care
- CIO Real Estate
- Exchange
- PRME Nasdaq
- CIO Nasdaq
- Market Cap
- PRME 191.7M
- CIO 221.6M
- IPO Year
- PRME 2022
- CIO 2014
- Fundamental
- Price
- PRME $4.21
- CIO $6.93
- Analyst Decision
- PRME Buy
- CIO Hold
- Analyst Count
- PRME 6
- CIO 1
- Target Price
- PRME $9.38
- CIO N/A
- AVG Volume (30 Days)
- PRME 5.8M
- CIO 758.0K
- Earning Date
- PRME 08-08-2025
- CIO 07-31-2025
- Dividend Yield
- PRME N/A
- CIO 5.80%
- EPS Growth
- PRME N/A
- CIO N/A
- EPS
- PRME N/A
- CIO N/A
- Revenue
- PRME $3,846,000.00
- CIO $168,891,000.00
- Revenue This Year
- PRME $104.12
- CIO $1.13
- Revenue Next Year
- PRME $108.24
- CIO $3.73
- P/E Ratio
- PRME N/A
- CIO N/A
- Revenue Growth
- PRME 550.76
- CIO N/A
- 52 Week Low
- PRME $1.11
- CIO $4.19
- 52 Week High
- PRME $5.95
- CIO $6.93
- Technical
- Relative Strength Index (RSI)
- PRME 60.42
- CIO 80.10
- Support Level
- PRME $3.71
- CIO $5.34
- Resistance Level
- PRME $5.15
- CIO $5.85
- Average True Range (ATR)
- PRME 0.53
- CIO 0.15
- MACD
- PRME -0.06
- CIO 0.11
- Stochastic Oscillator
- PRME 34.25
- CIO 99.69
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.